Connect with:
Tuesday / December 3. 2024
HomePosts Tagged "Financial results for Q2 FY25"

India Pesticides Limited delivered strong performance on both YoY and QoQ basis earning total revenue of Rs. 234 Crore showcasing growth at the rate of 13.6 per cent YoY and 4.5% QoQ

India Pesticides Limited (BSE: 543311; NSE: IPL), one of the fast growing agro-chemical companies for technical manufacturing (″IPL″ or the ″Company″), announced its results for quarter and half year ended September 30th, 2024.

Q2 & H1 FY25 Financial Performance:

(Rs. In Cr.)Q2 FY25Q2 FY24YoY
%
Q1 FY25QoQ
%
H1 FY25H1 FY24YoY
%
Total Income23420613.6%2244.5%45841111.5%
Gross Profit1057735.8%8819.7%19315127.8%
Gross Margin (%)44.8%37.5%39.1%42.0%36.7%
EBITDA393125.2%3222.1%715723.9%
EBITDA Margin (%)16.6%15.1%14.2%15.5%13.9%
EBIT342725.8%2824.4%625024.6%
EBIT Margin (%)14.7%13.3%12.4%13.6%12.2%
PAT262032.9%1933.0%453529.6%
PAT Margin (%)11.1%9.5%8.7%9.9%8.5%

Q2 FY25 Key Performance Highlights:

i. Total Income was Rs. 234 Crore, an increase of 13.6% and 4.5 per cent on YoY and QoQ respectively

ii. EBITDA of Rs. 39 Crore, an increase of 25.2 per cent on YoY with EBITDA margin of 16.6 per cent

iii. Net Profit of Rs. 26 Cr, an increase of 32.9 per cent on YoY with PAT margin of 11.1 per cent

H1 FY25 Key Performance Highlights:

i. Total Income was Rs. 458 Crore, an increase of 11.5 per cent on YoY basis

ii. EBITDA of Rs. 71 Crore, an increase of 23.9 per cent on YoY with EBITDA margin of 15.5 per cent

iii. Net Profit of Rs. 45 Cr, an increase of 29.6 per cent on YoY with PAT margin of 9.9 per cent

iv. Cash Flow from Operations stood at Rs.17 Crore

India Pesticides Limited delivered strong performance on

Company’s Crop Nutrition Business (CNB) achieved a remarkable 83 per cent YoY increase in sales volume of manufactured bulk fertilizer, which is highest ever sales.

Deepak Fertilisers and Petrochemicals Corporation Limited (DFPCL), one of India’s leading producers of industrial and mining chemicals and fertilisers, announced its results for the quarter ended September 30, 2024. Company’ s EBITDA Margin improved to 18 per cent compared to 12 per cent year-over-year. Company’s Crop Nutrition Business (CNB) achieved a remarkable 83 per cent YoY increase in sales volume of manufactured bulk fertilizer, which is the highest ever sales.

Commenting on the performance, Sailesh C. Mehta, Chairman & Managing Director said, DFPCL has shown impressive performance in Q2 FY25, achieving a 13 per cent growth in revenue. This growth was primarily driven by the Crop Nutrition business, which experienced an 18 per cent YoY increase in revenue, while the Chemical business grew by 8 per cent YoY despite a lean quarter for the chemical sectors.

“Fertilizer and Chemical businesses acted as a natural hedge, enabling the company to deliver consistent and improved performance.

“There has been a consistent increase in the proportion of revenue from specialty products, along with an overall rise in revenue, driven by the strategic move of transitioning from commodity to specialty,” says Mehta.

The ammonia plant has enabled all our businesses to reap substantial benefits from backward integration, effectively mitigating supply chain risks and price volatility. As a result, we are now able to capture the increases in global ammonia prices within the group.

As India continues to grow, the chemical and fertilizer sectors are poised to thrive. The demand outlook for the Crop Nutrition, Mining Chemicals, and Industrial Chemicals Business is well aligned with India’s growth story, providing strong and positive tailwinds. We are actively working on the execution of the TAN Project and the Nitric Acid Project in Gopalpur and Dahej, respectively, to capitalize on future growth.

Crop Nutrition Business (Fertilisers) Review

In Q2 FY25, manufactured bulk fertilizer has achieved highest ever sales volume of 268 KMT, an 83 per cent YoY increase, driven by improved demand from above-average rains, which led to 102% Kharif crop sowing and positive market sentiment across all regions.

Sales volume of Croptek surged to 37 KMT, reflecting a 70 per cent YoY growth, with continued focus on providing crop-specific solutions for targeted crops, including cotton, soybean, sugarcane, corn, grapes, pomegranate, and banana.

The company has recently launched premium water-soluble fertilizer grades. Sale of specialty fertilizer Bensulf was 9 KMT, up 7 per cent YoY.

Company’s Crop Nutrition Business (CNB) achieved a

Company’s Profit After Tax stood at Rs. 538.310 million in Q2FY25.

Praj Industries (Praj), announced its unaudited financial results for the quarter ended Sept 30, 2024.Company’s income from operations stood at Rs. 8,161.920 million in Q2FY25 (Q1 FY25: Rs. 6,991.414 million; Q2 FY24: Rs 8,823.685 million). Company reported Profit Before Tax (PBT) Rs 744.419 million for the period (Q1 FY25: Rs. 788.805 million; Q2 FY24: Rs 848.121 million). Company’s Profit After Tax is at Rs. 538.310 million in Q2FY25 (Q1 FY25: Rs. 841.807 million; Q2 FY24: 623.679 million). Order intake during the quarter Rs. 9,210 million (Q1 FY25: 8,880 million; Q2 FY24: Rs. 10,630 million)

In H1FY25 Company’s Income from operations stood at Rs. 15,153.334 million (H1 FY24: Rs. 16,190.912 million). Company’s PBT before exceptional items is at Rs. 1,533.224 million for the period (H1 FY24: Rs. 1,625.154 million). PBT after exceptional items Rs. 1,814.796 million. In H1FY25 company’s PAT stood at Rs. 1,380.117 million (H1 FY24: Rs. 1,210.405 million). Order intake Rs.18,090 million (H1 FY24: Rs. 21,640 million)

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “The Bioenergy segment continues to develop positively as we witness our business growing in multiple dimensions, with healthy order and enquiry inflows from international, services and engineering verticals in the first half of the year. Several positive developments in the ecosystem and market augur well for continued growth journey as we move forward. Commissioning of our Demo plant for biopolymers opens a completely new dimension in form of renewable chemicals and materials segment. Our strong focus on R&D backed solutions will continue help us stay on our envisioned growth path”.

Key Developments:

 Inauguration of India’s first-of-its-kind Demo Facility for Biopolymers, showcasing indigenously developed integrated Polylactic Acid (PLA) technology at the hands of Union Minister, Dr Jitendra Singh, Ministry of Science & Technology, in the presence of Dr Rajesh Gokhale, Secretary, Dept. of Biotechnology (DBT) and Dr. Ashish Lele (NCL).

Company’s Profit After Tax stood at Rs.

Company posted Revenue from Operations at Rs. 746.6 Crore in Q2 FY25.

Best Agrolife Limited, amongst India’s leading agrochemicals manufacturers, announced its unaudited financial results for the quarter and half year ended September 30th, 2024, in the Board meeting held on 18th October, 2024.

 Company’s Q2 FY25 Revenue from Operations declined by 8 per cent YoY to Rs. 746.6 crore in Q2 FY25 compared to Rs. 811.2 crore in Q2 FY24 due to lesser sprays on account of continuous rains and a strategic higher focus on branded sales. Branded sales contributed 65 per cent to the overall revenue as compared to 63 per cent in Q2FY24. Q2 FY25 EBITDA was at Rs. 147.1 crore compared to Rs. 144.1 crore in Q2 FY24. EBITDA margin stood at 19.7 per cent with an increase of 193 Bps on YoY basis, mainly on account of stability in raw material prices & higher sales of branded products. Company’s Q2 FY25 PAT stood at Rs. 94.7 crore compared to Rs. 94.9 crore in Q2 FY24. As on September 30, 2024, the Net Debt to equity has improved to 0.59 as compared to 0.90 as on 31st March 2024.

Commenting on the result and overall update on the Q2 FY25, Vimal Kumar, Managing Director, Best Agrolife Ltd. said, “We are pleased to announce that Best Agrolife Ltd. has delivered a strong performance in Q2 FY25, capitalising on favourable market conditions and executing our strategic shift toward branded sales. Our commitment to enhancing brand visibility and expanding our market presence has yielded positive results, contributing significantly to both top-line and bottom-line growth.”

During H1 FY25, we secured three key patents for our innovative formulations, reinforcing our leadership in the crop protection segment. Our branded products continued to perform exceptionally well across regions, driving overall revenue growth. As a result of these efforts, we saw a substantial improvement in profitability, with our margins expanding from 26 per cent to 34 per cent year-on-year.

Due to our effective working capital management, we have seen a significant improvement in cash flow from operating activities, rising from Rs 5 crores in H1FY24 to Rs 125 crores in H1FY25, reflecting our ongoing focus on optimizing financial performance.

A notable achievement has been the effective management of sales returns-a challenge we faced in the previous fiscal year. By optimizing our supply chain to better align with channel demand, we successfully reduced sales returns, which are expected to remain significantly lower than last year.

“Looking ahead, we are excited about our strong product pipeline for Q3 and Q4 FY25. In the upcoming quarter, we plan to launch our patented herbicide ‘Shot Down’ alongside a new insecticide. Additionally, two more cutting-edge insecticides are slated for release in Q4, further strengthening our product portfolio and market competitiveness. As we move forward, Best Agrolife remains committed to leveraging innovation, expanding brand presence, and maintaining financial discipline to drive sustainable growth in the coming quarters.”

Business Highlights

The Company was granted a patent for its novel ternary pesticide formulation that integrates Isoprothiolane, Pymetrozine, and Trifloxystrobin; as well as one for its fungicide formulation that combines Trifloxystrobin and Valifenalate.

Best Agrolife received a patent for innovative insecticide formulation ‘Nemagen’ that combines Chlorantraniliprole, Novaluron, and Emamectin Benzoate.

The Company received regulatory approval for Nemagen, an insecticide formulation called to target resistant pests causing major crop damage.

Company posted Revenue from Operations at Rs.